4.7 Article

Deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: A double-blinded randomized controlled study and long-term follow-up in eight patients

期刊

JOURNAL OF AFFECTIVE DISORDERS
卷 227, 期 -, 页码 521-529

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2017.11.024

关键词

Affective disorders; Deep brain stimulation; Subcallosal cingulate gyrus; Cg25; Depression; Treatment-resistant

资金

  1. Medtronic
  2. Medtronic Europe SARL (Meerbusch, Germany)
  3. Prof. Klaus Thiemann Foundation (Thiemann Fellowship)
  4. Stiftung Charite (Max Rubner Prize)
  5. Berlin Institute of Health (Clinical Scientist Programme)

向作者/读者索取更多资源

Background: Deep brain stimulation (DBS) of the subcallosal cingulate gyrus (SCG) is an experimental approach in treatment-resistant depression (TRD). Short-term results of efficacy in DBS are incongruent and studies investigating long-term effects are warranted. Methods: We assessed efficacy of SCG-DBS in eight patients randomized into a delayed-onset group (sham-DBS four weeks) and a non-delayed-onset group. The primary outcome measure was improvement on the Hamilton Depression Rating-Scale (HAMD-24-item-version). Response was defined as HAMD-24 reduction of at least 50% compared to baseline. Assessment was double-blind for a period of eight weeks and after 6,-12,-24,- and 28,months open-label. Results: The average improvement in HAMD-24 scores after 6,-12,- and 24-months were 34%, 25%, and 37%. After 6 months, HAMD-24 revealed a significant difference (P = .022) and 37.5% of the patients were responders. After 12 months, HAMD-24 scores dropped, but no significant difference was observed. After 24 months, a significant improvement was found (P = .041). After the four weeks lasting sham vs. DBS-ON period, there was no group difference (P = .376) in HAMD-24 and patients did not improve during sham stimulation. Patients were followed until 28 months and two up to 4 years under SCG-DBS and average response rate was 51%, whereas two patients were remitters (33,3%). Limitations: The small sample size limited the statistical power and external validity. Conclusions: Long-term improvement after SCG-DBS revealed a stable effect. There was no significant difference in response rates between the delayed and non-delayed-onset group. DBS for TRD remains experimental and longitudinal investigations of large samples are needed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据